A few months earlier, there were troubling signs of other contaminated CBD products, all the way on the other side of the country. A researcher at Virginia Commonwealth University heard about a person who felt extremely high after using a CBD vape pen. Alarmed, the researcher-Michelle Peace, Ph.D., associate professor in the department of forensic science-and her team decided to test the product to see what was going on. "There was nothing unusual looking about the products," she says. But her testing showed that, as in Utah, CiaoHealth the vaping liquid contained a dangerous form of synthetic cannabinoid. In this case, it was 5-fluoro MDMB-PINACA or 5F-ADB, a compound that can trigger paranoia and panic attacks, increase heart rate and blood pressure, and cause convulsions, organ damage, and even death, according to the Drug Enforcement Agency. And the test found something else, too: One product contained over-the-counter cough medicine dextromethorphan, which has a reputation, especially in teens, for being able to get users high.

" Peace says. "But the dextromethorphan was a surprise." She and colleagues are testing additional samples of the same products now and hope to have results by this summer. Those may be extreme examples, but adulterated, contaminated, or mislabeled CBD products aren’t isolated occurrences. A 2017 study published in JAMA by researchers at Johns Hopkins School of Medicine and University of Pennsylvania Perelman School of Medicine found that more than two-thirds of the products they purchased online were mislabeled, containing more CBD than listed on the label, less of it, or none at all. The tests also found some CBD products with more THC than listed on the label, sometimes much more. And, in the last three years, tests conducted by the Food and Drug Administration of CBD products found that many did not contain the levels of CBD they claimed to contain, says Michael Felberbaum, a spokesperson with the agency. The FDA sent warning letters to each.

And just last month, the agency and the Federal Trade Commission cited three additional companies-Advanced Spine and Pain (dba Relievus), Nutra Pure, and PotNetwork Holdings-for making unapproved Ciao Health CBD|Ciao Health|CiaoHealthCBD.net|www.CiaoHealthCBD.net|Ciao Health CBD Gummies|Ciao CBD|CiaoHealth|CiaoHealthCBD|Ciao Health Review|Ciao Health CBD Review|Ciao CBD Gummies|Ciao Health CBD Oil|Ciao Health Supplement|Ciao Health Formula|Ciao Hemp Extract|Buy Ciao Health CBD|Order Ciao Health|Ciao Health Website|Try Ciao Health|Get Ciao Health CBD claims that include, among other things, promoting CBD as a treatment for cancer, Alzheimer’s disease, or diabetes. As CBD has become federally legal and finds it way into the mainstream-a 2019 Consumer Reports survey found that 26THC are known as cannabinoids. They have very similar chemical structures and activate the same receptors within the body’s endocannabinoid system. Despite their similarity in structure, CBD and THC exert entirely different effects. The most significant difference between these two compounds is that THC is psychoactive. This means it can affect how the brain works. THC activates the body’s "reward" pathways to produce the "high" that’s associated with marijuana use. It does this by activating a cannabinoid receptor called CB1. When THC activates this type of receptor, things like movement, body temperature, and brain function are affected. In contrast, CBD is not considered psychoactive. It does not cause euphoria or a "high," even at large doses.